Utah Medical Products Stock Fundamentals
| UTMD Stock | USD 57.30 0.45 0.79% |
Utah Medical Products fundamentals help investors to digest information that contributes to Utah Medical's financial success or failures. It also enables traders to predict the movement of Utah Stock. The fundamental analysis module provides a way to measure Utah Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Utah Medical stock.
Utah |
Utah Medical Products Company Return On Equity Analysis
Utah Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Utah Medical Return On Equity | 0.11 |
Most of Utah Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Utah Medical Products is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Utah Medical Products has a Return On Equity of 0.1129. This is 100.47% lower than that of the Health Care Equipment & Supplies sector and 101.89% lower than that of the Health Care industry. The return on equity for all United States stocks is 136.42% lower than that of the firm.
Utah Medical Products Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Utah Medical's current stock value. Our valuation model uses many indicators to compare Utah Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Utah Medical competition to find correlations between indicators driving Utah Medical's intrinsic value. More Info.Utah Medical Products is rated fourth in return on equity category among its peers. It is rated third in return on asset category among its peers reporting about 0.67 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Utah Medical Products is roughly 1.48 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Utah Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Utah Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Utah Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Utah Medical could also be used in its relative valuation, which is a method of valuing Utah Medical by comparing valuation metrics of similar companies.Utah Medical is currently under evaluation in return on equity category among its peers.
Utah Fundamentals
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0762 | ||||
| Profit Margin | 0.34 % | ||||
| Operating Margin | 0.36 % | ||||
| Current Valuation | 109.74 M | ||||
| Shares Outstanding | 3.34 M | ||||
| Shares Owned By Insiders | 6.89 % | ||||
| Shares Owned By Institutions | 70.58 % | ||||
| Number Of Shares Shorted | 71.71 K | ||||
| Price To Earning | 31.38 X | ||||
| Price To Book | 1.64 X | ||||
| Price To Sales | 4.66 X | ||||
| Revenue | 50.22 M | ||||
| Gross Profit | 24.14 M | ||||
| EBITDA | 24.75 M | ||||
| Net Income | 16.64 M | ||||
| Cash And Equivalents | 69.51 M | ||||
| Cash Per Share | 19.17 X | ||||
| Total Debt | 295 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 13.44 X | ||||
| Book Value Per Share | 35.21 X | ||||
| Cash Flow From Operations | 22.28 M | ||||
| Short Ratio | 2.84 X | ||||
| Earnings Per Share | 3.96 X | ||||
| Beta | 0.06 | ||||
| Market Capitalization | 190.6 M | ||||
| Total Asset | 135.46 M | ||||
| Retained Earnings | 138.34 M | ||||
| Working Capital | 101.56 M | ||||
| Current Asset | 32.87 M | ||||
| Current Liabilities | 4.07 M | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.20 % | ||||
| Net Asset | 135.46 M | ||||
| Last Dividend Paid | 1.21 |
About Utah Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Utah Medical Products's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Utah Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Utah Medical Products based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company was incorporated in 1978 and is headquartered in Midvale, Utah. Utah Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 178 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:Check out Utah Medical Piotroski F Score and Utah Medical Altman Z Score analysis. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.